Literature DB >> 8430066

Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.

C Oliyai1, R T Borchardt.   

Abstract

In this study the hexapeptide Val-Tyr-Pro-Asp-Gly-Ala (Asp-hexapeptide) was used as a model to investigate the kinetics of aspartate degradation in aqueous solution. The apparent rate of degradation of the Asp-hexapeptide was determined as a function of pH, buffer concentration, and temperature. At very acidic pH levels (0.3, 1.1, 1.5, 2.0, and 3.0), the apparent rate of degradation followed pseudo-first-order kinetics. In this pH region, the Asp-hexapeptide predominantly underwent specific acid-catalyzed hydrolysis of the Asp-Gly amide bond (Asp-X hydrolysis) to form a tetrapeptide (Val-Tyr-Pro-Asp) and a dipeptide (Gly-Ala). In addition, parallel formation of a cyclic imide intermediate could be observed, although no iso-Asp-hexapeptide was detected. At pH 4.0 and 5.0, the Asp-hexapeptide simultaneously isomerized via the cyclic imide to form the iso-Asp-hexapeptide and underwent Asp-X hydrolysis to produce the cleavage products. The pH-rate profiles (pH 0.3-5.0) for the Asp-X hydrolysis and the formation of cyclic imide revealed that the degree of ionization of the carboxylic acid side chain of Asp residue significantly altered the rate of reaction, with the ionized form being more reactive than the unionized form. Little or no buffer catalysis was observed for either pathway. Solvent isotope experiments were used to probe the mechanism of the Asp-X hydrolysis reaction. At pH values above 6.0, the apparent rate of degradation of the Asp-hexapeptide followed pseudo-first-order reversible kinetics, with the iso-Asp-hexapeptide being the only observed product (isomerization).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430066     DOI: 10.1023/a:1018981231468

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides.

Authors:  K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Drug products of recombinant DNA technology.

Authors:  W J Black
Journal:  Am J Hosp Pharm       Date:  1989-09

Review 3.  Solvent isotope effects of enzyme systems.

Authors:  K B Schowen; R L Schowen
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  Cleavage at aspartic acid.

Authors:  A S Inglis
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 5.  The expression of isotope effects on enzyme-catalyzed reactions.

Authors:  D B Northrop
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Calcium affects the spontaneous degradation of aspartyl/asparaginyl residues in calmodulin.

Authors:  I M Ota; S Clarke
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

7.  Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone.

Authors:  N P Bhatt; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

8.  Synthetic peptide substrates for the erythrocyte protein carboxyl methyltransferase. Detection of a new site of methylation at isomerized L-aspartyl residues.

Authors:  E D Murray; S Clarke
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

9.  Mechanism and kinetics of secretion degradation in aqueous solutions.

Authors:  T Tsuda; M Uchiyama; T Sato; H Yoshino; Y Tsuchiya; S Ishikawa; M Ohmae; S Watanabe; Y Miyake
Journal:  J Pharm Sci       Date:  1990-03       Impact factor: 3.534

10.  Formation of epsilon-(aminosuccinyl)-lysine from epsilon-aspartyl-lysine from bacitracin A, and from the cell of lactobacilli.

Authors:  D L SWALLOW; E P ABRAHAM
Journal:  Biochem J       Date:  1958-11       Impact factor: 3.857

View more
  34 in total

1.  Effect of polyols on the conformational stability and biological activity of a model protein lysozyme.

Authors:  Somnath Singh; Jagdish Singh
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.

Authors:  June Kuang; Yuanqi Tao; Yuanli Song; Letha Chemmalil; Nesredin Mussa; Julia Ding; Zheng Jian Li
Journal:  Anal Bioanal Chem       Date:  2021-02-05       Impact factor: 4.142

3.  Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry.

Authors:  Lintao Wang; Godfrey Amphlett; John M Lambert; Walter Blättler; Wei Zhang
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

4.  A density functional theory study on peptide bond cleavage at aspartic residues: direct vs cyclic intermediate hydrolysis.

Authors:  Wichien Sang-aroon; Vittaya Amornkitbamrung; Vithaya Ruangpornvisuti
Journal:  J Mol Model       Date:  2013-11-17       Impact factor: 1.810

Review 5.  Fragmentation of monoclonal antibodies.

Authors:  Josef Vlasak; Roxana Ionescu
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 6.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

7.  Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.

Authors:  Sejal Gandhi; Da Ren; Gang Xiao; Pavel Bondarenko; Christopher Sloey; Margaret Speed Ricci; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2011-08-16       Impact factor: 4.200

Review 8.  Early engineering approaches to improve peptide developability and manufacturability.

Authors:  Jennifer L Furman; Mark Chiu; Michael J Hunter
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

9.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.

Authors:  David Ouellette; Chris Chumsae; Anca Clabbers; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2013-04-22       Impact factor: 5.857

10.  Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.

Authors:  Shanshan Liu; Kevin Ryan Moulton; Jared Robert Auclair; Zhaohui Sunny Zhou
Journal:  Amino Acids       Date:  2016-01-09       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.